Ortho Evra and Blood Clots

over 500 ortho evra lawsuits have been filed in the last two years on behalf of women who suffered blood clots and other serious side effects

Johnson & Johnson already settled several of the lawsuits charging that its patch causes blood clots and other serious side effects due to heightened levels. Several lawsuits have already ended with confidential , and the company has told plaintiffs lawyers it is ready to cut deals in remaining ones.

Learn more about Ortho Evra side effects.

do you need an ortho evra lawyer?

If you or a loved one have suffered serious side effects while taking , if you have been diagnosed with blood clots, heart attack, or stroke, or if you are experiencing the symptoms associated with any of these serious side effects, you may have a claim against the manufacturer of .

Please contact us today by filling out the brief questionnaire, or by calling our toll free number (1-800-898-2034) for a free, no-cost no-obligation evaluation of your case.


Latest News

Consumers should use caution with B-12 vitamin patch

b12 patch picture 100x100A patch-delivery system is now available to consumers who want or need more of the vitamin B-12, an essential vitamin that plays a key role in the normal functioning of the brain and nervous system and for the formation of blood. B-12 is naturally found in meat, shellfish, milk, eggs and fortified cereals, but many people’s digestive systems do not absorb enough B-12, which can lead to vitamin B-12 deficiency. A B-12 deficiency can contribute to anemia, which can leave you feeling weak, lightheaded, depressed and tired.

Read the rest of this entry »

More drug patches expected to hit market, but are they safe?

hand hold patch 128x150More than 40 drug development programs have transdermal systems, or drug patches, under development for either initial approval or expanded indications, according to Pharma Live. But can consumers trust their safety record?

Read the rest of this entry »

Canadian groups issue label change on birth control patch

Canadian pharmaceutical company Janssen-Ortho, Inc. in cooperation with Health Canada has issued a press release updating information on the average daily release rates of contraceptive hormones from the EVRA Transdermal Contraceptive System (patch) that is marketed in Canada and approved for use for the prevention of pregnancy. EVRA is bioequivalent to Ortho Evra, the birth control patch that is marketed in the United States.

Read the rest of this entry »